No Data
No Data
Top Gap Ups and Downs on Wednesday: INTU, XPEV, APP and More
TD Cowen Maintains United Therapeutics(UTHR.US) With Buy Rating, Maintains Target Price $400
Earnings Call Summary | United Therapeutics(UTHR.US) Q4 2024 Earnings Conference
Why United Therapeutics (UTHR) Stock Is Down Today
United Therapeutics Down Nearly 10%, on Pace for Largest Percent Decrease Since February 2022 -- Data Talk
Express News | United Therapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q4 Financial Results
Unlock the Full List